Analyst Ratings for Lyell Immunopharma (LYEL)
LYEL Rating Summary
LYEL Price Target Summary
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$32.50 (+44.7%)
* Over Last 12-Mos
Rating Score: 3.3 / 10
Percentile Rank: 30%
Avg. $ Target:
$32.50 (+44.7%)
* Over Last 12-Mos
Rating Score: 3.3 / 10
Percentile Rank: 30%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/9/2025 | H.C. Wainwright | Mitchell S. Kapoor | Upgrade | Buy (Neutral) |
45.00 (20.00) |
28.36 (22.46) |
-20.8% | Details |
| 9/26/2025 | Lucid Capital Markets | Christopher Liu | New Coverage | Buy (N/A) |
20.00 (N/A) |
12.72 (22.46) |
76.57% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
